Latest News
Graviton BioScience Corporation Announces Publication of Positive Ph1b Trial Results for GV101 (TDI01) in Chronic Graft versus Host Disease in Signal Transduction and Targeted Therapy, by Beijing Tide Pharmaceutical
GV101, a novel, highly selective ROCK2 inhibitor, yielded an 86.2% best overall response rate (bORR) at 400 mg and a 67.9% bORR at 200 mg at 24 weeks in chronic Graft versus Host Disease (cGvHD) patie
Faruqi & Faruqi, LLP Urges Regeneron Pharmaceuticals, Inc. (REGN) Investors to Seek Counsel Before the September 14, 2026 Lead Plaintiff Deadline in the Securities Class Action
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses in Regeneron to Contact Him Directly to Discuss Their Options New York, New York--(Newsf
Faruqi & Faruqi, LLP Urges Rackspace Technology, Inc. (RXT) Investors to Seek Counsel Before the September 28, 2026 Lead Plaintiff Deadline in the Securities Class Action
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses in Rackspace to Contact Him Directly to Discuss Their Options New York, New York--(Newsf
Kaplan Fox & Kilsheimer LLP is Investigating Hims & Hers Health, Inc. (HIMS) for Possible Securities Law Violations
New York, New York--(Newsfile Corp. - August 26, 2026) - Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against Hims & Hers Health, Inc. ("Hims & Hers" or the "Company")
Scott Bessent Hasn't Crashed The Market
Long-term US Treasury yields have surged, but equity markets and the VIX show little fear or contagion. The Fed's credibility is under scrutiny as inflation remains above target and policy action lags
Auburn National Bancorporation: Why I Will Initiate A Long Position
Auburn National Bancorporation leads the Lee County deposit market with robust loan quality and a $100M market cap. AUBN delivered strong H1 results, reversing loan loss provisions and posting $1.29 E
Kaplan Fox Reminds ARS Pharmaceuticals Inc. (SPRY) Investors of a Securities Class Action Deadline on October 5, 2026
New York, New York--(Newsfile Corp. - August 26, 2026) - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against ARS Pharmaceuticals Inc. ("ARS" or the "Company") (NAS
Canaccord Genuity reiterates Sell on 3i Infrastructure, calling shares fully valued
Canaccord Genuity (TSX:CF, LSE:CF) has reiterated its 'sell' rating on 3i Infrastructure PLC (LSE:3IN), saying the shares look fully valued following their recent rise. 3i Infrastructure's share price
Nykode Therapeutics AS (VACBF) Q2 2026 Earnings Call Transcript
Nykode Therapeutics AS (VACBF) Q2 2026 Earnings Call Transcript
Faruqi & Faruqi, LLP Urges UWM Holdings Corporation (UWMC) Investors to Seek Counsel Before the October 12, 2026 Lead Plaintiff Deadline in the Securities Class Action
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses in UWM to Contact Him Directly to Discuss Their Options New York, New York--(Newsfile Co
VPT's VXR and VPT Series DC-DC Converters, EMI Filters, and Accessories Now Available on DigiKey
BLACKSBURG, Va., Aug. 26, 2026 /PRNewswire/ -- VPT, Inc. (VPT®), a HEICO company (NYSE: HEI.A) (NYSE: HEI) and leading provider of high-reliability power conversion solutions for military, avionics, a
Anthropic's $30 Trillion And The Artificial Intelligence Bubble That Never Was
AI market valuations, such as Anthropic's potential $2 trillion IPO, appear justified if the projected $30 trillion AI market materializes. I view the risk of an AI bubble as overstated; productivity
Quantum Computing Is Raising the Stakes for Cybersecurity: 5 Stocks to Watch
In the near future, the mathematical horizon where quantum computing could break all traditional encryption is transitioning from a theoretical debate into a real corporate compliance deadline. Quantu
Warsh's Jackson Hole Silence May Push Long-Term Rates Much Higher
Kevin Warsh's Jackson Hole speech is a pivotal opportunity to demonstrate true policy independence amid Treasury efforts to manage the yield curve. Long-end rates have remained rangebound for years; r
Berger Montague PC Investigates Hims & Hers Health, Inc.'s Board of Directors for Breach of Fiduciary Duty (HIMS)
Philadelphia, Pennsylvania--(Newsfile Corp. - August 26, 2026) - National plaintiffs' law firm Berger Montague PC announces an investigation into the Board of Directors of Hims & Hers Health, Inc. (NY
Agora: Worth A Bet At Current Valuations
Agora has seen its stock post only modest gains YTD, but there is reason to think the potential to do better is there. Both the income statement and the balance sheet are in good shape according to th
SM Energy: Tailwinds From Fading Hedge Drag And Strong Oil Leverage
SM Energy is rated a strong buy with a $59/share target, implying 65% upside, based on discounted free cash flow modeling. The transformative Civitas acquisition more than doubled SM's acreage and pr
Faruqi & Faruqi, LLP Urges ARS Pharmaceuticals (SPRY) Investors to Seek Counsel Before the October 5, 2026 Lead Plaintiff Deadline in the Securities Class Action
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses in ARS Pharmaceuticals to Contact Him Directly to Discuss Their Options New York, New Yo
Olin: One-Time Problems Are A Buying Opportunity
Olin remains a valuable opportunity despite operational setbacks, sector headwinds, and a 12% share price decline over the past year. OLN's Q2 was impacted by a $40M Freeport outage, weak demand, and
A Mixed Year For Bonds Ahead Of Warsh's Jackson Hole Speech
The bond market has had a rocky year, but several fixed‑income sectors are posting gains so far in 2026, based on a set of ETFs through Aug. 25's close. Junk bonds and floating‑rate securities continu